Cube Biotech announces a leadership transition with Michael Bencak as the new CEO, effective immediately. Didier Dargent transitions to the role of Executive Chairman, providing guidance for the company's next phase.

Cube Biotech is an innovator in protein stabilization and purification technologies. The company focuses on advancing science and biotechnology to contribute to drug discovery. With a strong commitment to growth and transformation, Cube Biotech aims to enhance its global presence.

https://cube-biotech.com/

Biotechnology

Monheim am Rhein, Nordrhein-Westfalen, Germany

Cube Biotech Appoints Michael Bencak As Chief Executive Officer

Description

Company Information

Related People

Executive Insights